PGD2
Pgd2 is a lipid of Fatty Acyls (FA) class. Pgd2 is associated with abnormalities such as Inflammatory disorder, Pleurisy, Rhinitis, Dehydration and Pneumonia. The involved functions are known as antagonists, fat cell differentiation, Phosphorylation, Process and Gene Expression. Pgd2 often locates in Cell surface, Body tissue, Extracellular, Bone Marrow and Membrane. The associated genes with PGD2 are oxytocin, 1-desamino-(O-Et-Tyr)(2)-, P4HTM gene, PTGS2 gene, PTGDS gene and IL3 gene. The related lipids are 15-deoxyprostaglandin J2, Nonesterified Fatty Acids, Lipopolysaccharides, Steroids and Liposomes. The related experimental models are Knock-out and Rodent Model.
Cross Reference
Introduction
To understand associated biological information of PGD2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with PGD2?
PGD2 is suspected in Asthma, Dehydration, Allergic rhinitis NOS, Rhinitis, Infertility, Pneumonia and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with PGD2
PubChem Associated disorders and diseases
What pathways are associated with PGD2
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with PGD2?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with PGD2?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with PGD2?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with PGD2?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with PGD2?
Knock-out
Knock-out are used in the study 'Multiple roles of the prostaglandin D2 signaling pathway in reproduction.' (Rossitto M et al., 2015).
Rodent Model
Rodent Model are used in the study 'PKA regulatory IIα subunit is essential for PGD2-mediated resolution of inflammation.' (Kong D et al., 2016).
Related references are published most in these journals:
| Model | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
NCBI Entrez Crosslinks
All references with PGD2
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Schleimer RP et al. | Selective inhibition of arachidonic acid metabolite release from human lung tissue by antiinflammatory steroids. | 1986 | J. Immunol. | pmid:3082976 |
| Marx N et al. | Peroxisome proliferator-activated receptor-gamma activators inhibit IFN-gamma-induced expression of the T cell-active CXC chemokines IP-10, Mig, and I-TAC in human endothelial cells. | 2000 | J. Immunol. | pmid:10843708 |
| Chen CW et al. | Inhibition of IFN-gamma-mediated inducible nitric oxide synthase induction by the peroxisome proliferator-activated receptor gamma agonist, 15-deoxy-delta 12,14-prostaglandin J2, involves inhibition of the upstream Janus kinase/STAT1 signaling pathway. | 2003 | J. Immunol. | pmid:12847270 |
| Peters SP et al. | Arachidonic acid metabolism in purified human lung mast cells. | 1984 | J. Immunol. | pmid:6199420 |
| Patella V et al. | Eosinophil granule proteins activate human heart mast cells. | 1996 | J. Immunol. | pmid:8757629 |
| Nencioni A et al. | Dendritic cell immunogenicity is regulated by peroxisome proliferator-activated receptor gamma. | 2002 | J. Immunol. | pmid:12133943 |
| Columbo M et al. | The human recombinant c-kit receptor ligand, rhSCF, induces mediator release from human cutaneous mast cells and enhances IgE-dependent mediator release from both skin mast cells and peripheral blood basophils. | 1992 | J. Immunol. | pmid:1378071 |
| Kobayashi Y et al. | Physiological levels of 15-deoxy-Delta12,14-prostaglandin J2 prime eotaxin-induced chemotaxis on human eosinophils through peroxisome proliferator-activated receptor-gamma ligation. | 2005 | J. Immunol. | pmid:16237065 |
| Levi-Schaffer F et al. | Fibroblasts maintain the phenotype and viability of the rat heparin-containing mast cell in vitro. | 1985 | J. Immunol. | pmid:2413121 |
| Lewis RA et al. | Prostaglandin D2 generation after activation of rat and human mast cells with anti-IgE. | 1982 | J. Immunol. | pmid:6809826 |
| Urade Y et al. | The major source of endogenous prostaglandin D2 production is likely antigen-presenting cells. Localization of glutathione-requiring prostaglandin D synthetase in histiocytes, dendritic, and Kupffer cells in various rat tissues. | 1989 | J. Immunol. | pmid:2509561 |
| Yoon HJ et al. | Regulation of TLR2 expression by prostaglandins in brain glia. | 2008 | J. Immunol. | pmid:18523308 |
| Bissonnette SL et al. | An endogenous prostaglandin enhances environmental phthalate-induced apoptosis in bone marrow B cells: activation of distinct but overlapping pathways. | 2008 | J. Immunol. | pmid:18641309 |
| Patella V et al. | Human heart mast cells. Isolation, purification, ultrastructure, and immunologic characterization. | 1995 | J. Immunol. | pmid:7533185 |
| Leal-Berumen I et al. | Prostanoid enhancement of interleukin-6 production by rat peritoneal mast cells. | 1995 | J. Immunol. | pmid:7536779 |
| Cheron A et al. | 15-deoxy-Delta12,14-prostaglandin J2 inhibits glucocorticoid binding and signaling in macrophages through a peroxisome proliferator-activated receptor gamma-independent process. | 2004 | J. Immunol. | pmid:15187150 |
| Zingarelli B et al. | Peroxisome proliferator activator receptor-gamma ligands, 15-deoxy-Delta(12,14)-prostaglandin J2 and ciglitazone, reduce systemic inflammation in polymicrobial sepsis by modulation of signal transduction pathways. | 2003 | J. Immunol. | pmid:14662889 |
| Kuehn HS et al. | The phosphoinositide 3-kinase-dependent activation of Btk is required for optimal eicosanoid production and generation of reactive oxygen species in antigen-stimulated mast cells. | 2008 | J. Immunol. | pmid:19017959 |
| Hammad H et al. | Prostaglandin D2 inhibits airway dendritic cell migration and function in steady state conditions by selective activation of the D prostanoid receptor 1. | 2003 | J. Immunol. | pmid:14530310 |
| Xue L et al. | Novel function of CRTH2 in preventing apoptosis of human Th2 cells through activation of the phosphatidylinositol 3-kinase pathway. | 2009 | J. Immunol. | pmid:19494281 |
| Satoh T et al. | Prostaglandin D2 plays an essential role in chronic allergic inflammation of the skin via CRTH2 receptor. | 2006 | J. Immunol. | pmid:16888024 |
| Napimoga MH et al. | Exogenous administration of 15d-PGJ2-loaded nanocapsules inhibits bone resorption in a mouse periodontitis model. | 2012 | J. Immunol. | pmid:22706081 |
| Schulman ES et al. | Histochemical heterogeneity of dispersed human lung mast cells. | 1990 | J. Immunol. | pmid:1692857 |
| Menè P | Prostaglandin D2 : a Cinderella of vascular cell biology? | 2002 | J. Hypertens. | pmid:12131515 |
| Negoro H et al. | Endogenous prostaglandin D2 synthesis reduces an increase in plasminogen activator inhibitor-1 following interleukin stimulation in bovine endothelial cells. | 2002 | J. Hypertens. | pmid:12131531 |
| Han XQ et al. | Advanced glycation end products promote differentiation of CD4(+) T helper cells toward pro-inflammatory response. | 2014 | J. Huazhong Univ. Sci. Technol. Med. Sci. | pmid:24496672 |
| Zhang M et al. | Peroxisome proliferator-activated receptor-gamma activated by ligands can inhibit human lung cancer cell growth through induction of apoptosis. | 2003 | J. Huazhong Univ. Sci. Technol. Med. Sci. | pmid:12973930 |
| López-Parra M et al. | The selective cyclooxygenase-2 inhibitor celecoxib modulates the formation of vasoconstrictor eicosanoids and activates PPARgamma. Influence of albumin. | 2005 | J. Hepatol. | pmid:15629510 |
| Tran-Thi TA et al. | Net prostaglandin release by perfused rat liver after stimulation with phorbol 12-myristate 13-acetate. | 1988 | J. Hepatol. | pmid:3166024 |
| Hoffmann R et al. | Regulation of interleukin-6 receptor expression in rat Kupffer cells: modulation by cytokines, dexamethasone and prostaglandin E2. | 1994 | J. Hepatol. | pmid:7814800 |
| Gressner OA et al. | Pharmacological application of caffeine inhibits TGF-beta-stimulated connective tissue growth factor expression in hepatocytes via PPARgamma and SMAD2/3-dependent pathways. | 2008 | J. Hepatol. | pmid:18486259 |
| Li L et al. | Molecular mechanisms regulating the antifibrogenic protein heme-oxygenase-1 in human hepatic myofibroblasts. | 2004 | J. Hepatol. | pmid:15336443 |
| Tran-Thi TA et al. | Effects of hypoxia on the oxygen-dependent metabolism of prostaglandins and adenosine in liver cells. | 1994 | J. Hepatol. | pmid:8071531 |
| Tran-Thi TA et al. | Studies on synthesis and degradation of eicosanoids by rat hepatocytes in primary culture. | 1987 | J. Hepatol. | pmid:2828463 |
| Santoro MG et al. | PGJ2, a new antiviral prostaglandin: inhibition of Sendai virus replication and alteration of virus protein synthesis. | 1987 | J. Gen. Virol. | pmid:3033130 |
| Rollins MD et al. | Anti-inflammatory effects of PPAR-gamma agonists directly correlate with PPAR-gamma expression during acute pancreatitis. | 2006 Sep-Oct | J. Gastrointest. Surg. | pmid:16966031 |
| Yamamoto Y et al. | Role of peroxisome proliferator-activated receptor-gamma (PPARgamma) during liver regeneration in rats. | 2008 | J. Gastroenterol. Hepatol. | pmid:18565023 |
| Berruyer C et al. | Vanin-1 licenses inflammatory mediator production by gut epithelial cells and controls colitis by antagonizing peroxisome proliferator-activated receptor gamma activity. | 2006 | J. Exp. Med. | pmid:17145956 |
| Mellor EA et al. | Cysteinyl leukotrienes and uridine diphosphate induce cytokine generation by human mast cells through an interleukin 4-regulated pathway that is inhibited by leukotriene receptor antagonists. | 2002 | J. Exp. Med. | pmid:11877481 |
| Honda K et al. | Prostaglandin D2 reinforces Th2 type inflammatory responses of airways to low-dose antigen through bronchial expression of macrophage-derived chemokine. | 2003 | J. Exp. Med. | pmid:12925672 |
| Murakami M et al. | The immediate phase of c-kit ligand stimulation of mouse bone marrow-derived mast cells elicits rapid leukotriene C4 generation through posttranslational activation of cytosolic phospholipase A2 and 5-lipoxygenase. | 1995 | J. Exp. Med. | pmid:7540649 |
| Chilton FH et al. | Antigen-induced generation of lyso-phospholipids in human airways. | 1996 | J. Exp. Med. | pmid:8642333 |
| Angeli V et al. | Role of the parasite-derived prostaglandin D2 in the inhibition of epidermal Langerhans cell migration during schistosomiasis infection. | 2001 | J. Exp. Med. | pmid:11369785 |
| Hirai H et al. | Prostaglandin D2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor CRTH2. | 2001 | J. Exp. Med. | pmid:11208866 |
| Hammad H et al. | Activation of the D prostanoid 1 receptor suppresses asthma by modulation of lung dendritic cell function and induction of regulatory T cells. | 2007 | J. Exp. Med. | pmid:17283205 |
| Kilunga Kubata B et al. | Plasmodium falciparum produces prostaglandins that are pyrogenic, somnogenic, and immunosuppressive substances in humans. | 1998 | J. Exp. Med. | pmid:9743538 |
| Kubata BK et al. | Identification of a novel prostaglandin f(2alpha) synthase in Trypanosoma brucei. | 2000 | J. Exp. Med. | pmid:11067881 |
| Kubata BK et al. | A key role for old yellow enzyme in the metabolism of drugs by Trypanosoma cruzi. | 2002 | J. Exp. Med. | pmid:12417633 |
| Hsieh FH et al. | T helper cell type 2 cytokines coordinately regulate immunoglobulin E-dependent cysteinyl leukotriene production by human cord blood-derived mast cells: profound induction of leukotriene C(4) synthase expression by interleukin 4. | 2001 | J. Exp. Med. | pmid:11136826 |
| Kong D et al. | PKA regulatory IIα subunit is essential for PGD2-mediated resolution of inflammation. | 2016 | J. Exp. Med. | pmid:27621415 |
| Tasaka K et al. | Prostaglandin D2 induces release of luteinizing hormone from the rat pituitary gland without the modulation of hypothalamic luteinizing hormone releasing hormone. | 1983 | J. Endocrinol. | pmid:6361197 |
| Kurtz M et al. | Peroxisome proliferator-activated receptor ligands regulate lipid content, metabolism, and composition in fetal lungs of diabetic rats. | 2014 | J. Endocrinol. | pmid:24389592 |
| Knepel W et al. | Inhibition by prostaglandin E2 of the release of vasopressin and beta-endorphin from rat pituitary neurointermediate lobe or medial basal hypothalamus in vitro. | 1985 | J. Endocrinol. | pmid:3160802 |
| Löhrke B et al. | Detection and functional characterisation of the transcription factor peroxisome proliferator-activated receptor gamma in lutein cells. | 1998 | J. Endocrinol. | pmid:9834460 |
| Takano H and Komuro I | Roles of peroxisome proliferator-activated receptor gamma in cardiovascular disease. | 2002 Jan-Feb | J. Diabetes Complicat. | pmid:11872377 |
| Goya K et al. | The thiazolidinedione drug troglitazone up-regulates nitric oxide synthase expression in vascular endothelial cells. | 2006 Sep-Oct | J. Diabetes Complicat. | pmid:16949522 |
| Soifer SJ et al. | The developmental effects of prostaglandin D2 on the pulmonary and systemic circulations in the newborn lamb. | 1983 | J. Dev. Physiol. | pmid:6579103 |
| Hau CS et al. | Suppressive effects of antimycotics on thymic stromal lymphopoietin production in human keratinocytes. | 2013 | J. Dermatol. Sci. | pmid:23688403 |
| Pierron A et al. | PGJ2 restores RA sensitivity in melanoma cells by decreasing PRAME and EZH2. | 2014 | J. Dermatol. Sci. | pmid:24289988 |
| Amon U et al. | Investigations on plasma levels of mast cell mediators in acute atopic dermatitis. | 1994 | J. Dermatol. Sci. | pmid:8193085 |
| Schütz TC et al. | Effects of COX-2 inhibitor in temporomandibular joint acute inflammation. | 2007 | J. Dent. Res. | pmid:17452571 |
| Fukuchi K et al. | Apoptosis in human oral squamous cell carcinomas is induced by 15-deoxy-delta 12,14-prostaglandin J2 but not by troglitazone. | 2003 | J. Dent. Res. | pmid:14514760 |
| Lutzow YS et al. | 15-Deoxy-Delta12,14-prostaglandin J2 induces chemokine expression, oxidative stress and microfilament reorganization in bovine mammary epithelial cells. | 2008 | J. Dairy Res. | pmid:18226310 |
| Kunkel SL et al. | Suppression of immune complex vasculitis in rats by prostaglandin. | 1979 | J. Clin. Invest. | pmid:159314 |
| Rozera C et al. | Inhibition of HIV-1 replication by cyclopentenone prostaglandins in acutely infected human cells. Evidence for a transcriptional block. | 1996 | J. Clin. Invest. | pmid:8621762 |
| Benyó Z et al. | GPR109A (PUMA-G/HM74A) mediates nicotinic acid-induced flushing. | 2005 | J. Clin. Invest. | pmid:16322797 |
| Zhao J et al. | Age-related increases in PGD(2) expression impair respiratory DC migration, resulting in diminished T cell responses upon respiratory virus infection in mice. | 2011 | J. Clin. Invest. | pmid:22105170 |
| Braciale TJ and Kim TS | Slowing down with age: lung DCs do it too. | 2011 | J. Clin. Invest. | pmid:22105176 |
| Weinreich D and Undem BJ | Immunological regulation of synaptic transmission in isolated guinea pig autonomic ganglia. | 1987 | J. Clin. Invest. | pmid:2437156 |
| Adler DH et al. | Inherited human cPLA(2alpha) deficiency is associated with impaired eicosanoid biosynthesis, small intestinal ulceration, and platelet dysfunction. | 2008 | J. Clin. Invest. | pmid:18451993 |
| Kawahito Y et al. | 15-deoxy-delta(12,14)-PGJ(2) induces synoviocyte apoptosis and suppresses adjuvant-induced arthritis in rats. | 2000 | J. Clin. Invest. | pmid:10903334 |
| Togias AG et al. | Nasal challenge with cold, dry air results in release of inflammatory mediators. Possible mast cell involvement. | 1985 | J. Clin. Invest. | pmid:2414318 |
| Creticos PS et al. | Nasal challenge with ragweed pollen in hay fever patients. Effect of immunotherapy. | 1985 | J. Clin. Invest. | pmid:2416777 |
| Adams M et al. | Activators of peroxisome proliferator-activated receptor gamma have depot-specific effects on human preadipocyte differentiation. | 1997 | J. Clin. Invest. | pmid:9399962 |
| Passeron T et al. | Upregulation of SOX9 inhibits the growth of human and mouse melanomas and restores their sensitivity to retinoic acid. | 2009 | J. Clin. Invest. | pmid:19273910 |
| Charlesworth EN et al. | Cutaneous late-phase response to allergen. Mediator release and inflammatory cell infiltration. | 1989 | J. Clin. Invest. | pmid:2468688 |
| Schulman ES et al. | Differential effects of the complement peptides, C5a and C5a des Arg on human basophil and lung mast cell histamine release. | 1988 | J. Clin. Invest. | pmid:2449462 |
| Pipkorn U et al. | Effect of short-term systemic glucocorticoid treatment on human nasal mediator release after antigen challenge. | 1987 | J. Clin. Invest. | pmid:2443539 |
| Schleimer RP et al. | Effects of dexamethasone on mediator release from human lung fragments and purified human lung mast cells. | 1983 | J. Clin. Invest. | pmid:6134755 |
| Powell WS | 15-Deoxy-delta12,14-PGJ2: endogenous PPARgamma ligand or minor eicosanoid degradation product? | 2003 | J. Clin. Invest. | pmid:12975467 |
| Bell-Parikh LC et al. | Biosynthesis of 15-deoxy-delta12,14-PGJ2 and the ligation of PPARgamma. | 2003 | J. Clin. Invest. | pmid:12975479 |
| Tokudome S et al. | Glucocorticoid protects rodent hearts from ischemia/reperfusion injury by activating lipocalin-type prostaglandin D synthase-derived PGD2 biosynthesis. | 2009 | J. Clin. Invest. | pmid:19451694 |
| Su CG et al. | A novel therapy for colitis utilizing PPAR-gamma ligands to inhibit the epithelial inflammatory response. | 1999 | J. Clin. Invest. | pmid:10449430 |
| Beasley CR et al. | 9 alpha,11 beta-prostaglandin F2, a novel metabolite of prostaglandin D2 is a potent contractile agonist of human and guinea pig airways. | 1987 | J. Clin. Invest. | pmid:3469218 |
| Song WL et al. | Niacin and biosynthesis of PGDâ‚‚by platelet COX-1 in mice and humans. | 2012 | J. Clin. Invest. | pmid:22406532 |
| Chearwae W and Bright JJ | 15-deoxy-Delta(12,14)-prostaglandin J(2) and curcumin modulate the expression of toll-like receptors 4 and 9 in autoimmune T lymphocyte. | 2008 | J. Clin. Immunol. | pmid:18463970 |
| Kawano S et al. | Protective effect of PGD2 against ethanol-induced gastric mucosal injury in rats. | 1990 | J. Clin. Gastroenterol. | pmid:2212542 |
| Kasim-Karakas SE et al. | Metabolic and endocrine effects of a polyunsaturated fatty acid-rich diet in polycystic ovary syndrome. | 2004 | J. Clin. Endocrinol. Metab. | pmid:14764771 |
| Mitchell MD et al. | Identification of 9alpha,11beta-prostaglandin F2 in human amniotic fluid and characterization of its production by human gestational tissues. | 2005 | J. Clin. Endocrinol. Metab. | pmid:15840748 |
| Schaiff WT et al. | Peroxisome proliferator-activated receptor-gamma modulates differentiation of human trophoblast in a ligand-specific manner. | 2000 | J. Clin. Endocrinol. Metab. | pmid:11061552 |
| Helliwell RJ et al. | Gestational age-dependent up-regulation of prostaglandin D synthase (PGDS) and production of PGDS-derived antiinflammatory prostaglandins in human placenta. | 2006 | J. Clin. Endocrinol. Metab. | pmid:16291703 |
| Lappas M et al. | Regulation of proinflammatory cytokines in human gestational tissues by peroxisome proliferator-activated receptor-gamma: effect of 15-deoxy-Delta(12,14)-PGJ(2) and troglitazone. | 2002 | J. Clin. Endocrinol. Metab. | pmid:12364456 |
| Carr BR et al. | Prostaglandin secretion by the neocortex and fetal zones of the human fetal adrenal gland. | 1983 | J. Clin. Endocrinol. Metab. | pmid:6313732 |
| Lindström TM and Bennett PR | 15-Deoxy-{delta}12,14-prostaglandin j2 inhibits interleukin-1{beta}-induced nuclear factor-{kappa}b in human amnion and myometrial cells: mechanisms and implications. | 2005 | J. Clin. Endocrinol. Metab. | pmid:15755849 |
| Schwartz MS et al. | Determination of a prostaglandin D2 antagonist and its acyl glucuronide metabolite in human plasma by high performance liquid chromatography with tandem mass spectrometric detection--a lack of MS/MS selectivity between a glucuronide conjugate and a phase I metabolite. | 2006 | J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. | pmid:16716772 |
| Schmidt R et al. | LC-MS/MS-analysis of prostaglandin E2 and D2 in microdialysis samples of rats. | 2005 | J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. | pmid:16172029 |
| Morrow JD and Minton TA | Improved assay for the quantification of 11-dehydrothromboxane B2 by gas chromatography-mass spectrometry. | 1993 | J. Chromatogr. | pmid:8468374 |
| Chiabrando C et al. | Quantitative profiling of prostaglandins and thromboxane by high-resolution gas chromatography-selected--ion monitoring. | 1983 | J. Chromatogr. | pmid:6584432 |
| Zhao X et al. | 15d-Prostaglandin J2 activates peroxisome proliferator-activated receptor-gamma, promotes expression of catalase, and reduces inflammation, behavioral dysfunction, and neuronal loss after intracerebral hemorrhage in rats. | 2006 | J. Cereb. Blood Flow Metab. | pmid:16208315 |
| Pereira MP et al. | Rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2 cause potent neuroprotection after experimental stroke through noncompletely overlapping mechanisms. | 2006 | J. Cereb. Blood Flow Metab. | pmid:16034372 |